Who decides you can have sermorelin

Almost everyone says a clinician decides

This is the part of the transaction sellers are comfortable describing. 79 of the 88 sermorelin pages we read use the word prescription, prescribed, prescriber or prescribing somewhere on them, and 78 name a consultation, an intake, a questionnaire or telehealth. The overlap is nearly total: only 3 pages of 88 name neither.

Fifteen say the money does not buy the yes

The sentence worth reading is the one that puts the payment and the decision in an order. On 15 of the 88 pages, the seller states outright that handing over money does not oblige anyone to write you a prescription.

It is a disclaimer rather than a warning, and it appears in the small print at the foot of a page whose top half is a price. But read as a description of the process it is precise: you pay first, and a provider decides afterwards. The pages that publish a refund term confirm the same order from the other direction, which is the next section.

Six companies, one sentence, word for word

6 of the 15 do not merely make the same point. They print the same twelve words, in the same order, with the same punctuation:

The six are AVARA Rx, Kin Meds, Remi Meds, TrueMe, Vital Harmony Rx and Wellspring Longevity Clinic. They are six separate companies with six separate brands, six separate price points and six separate websites, and on all six the sentence sits inside the same surrounding paragraph about independent medical practices. We counted it as an exact string rather than with a search, because the claim is that the wording is identical and a search with alternatives in it could not have supported that claim.

We do not know where the sentence originates and this site is not going to guess. What we can say is what it means for a reader: the legal shape of this market is written once and reused, so a disclaimer appearing on a page is evidence about a template rather than evidence about that particular company’s process. Elsewhere in these pages the same effect shows up in price ladders and side-effect lists that repeat across unrelated brands.

You can tell the order from the refund

Compare the refund and cancellation terms before entering payment details. Our provider buying guide keeps the medical evaluation, the medication quote and the payment commitment as separate checks.

8 pages of the 88 publish a money-back term whose stated condition is that the provider declined to prescribe. That is a refund of money taken for a drug the buyer was never sold, and it only makes sense in a flow where the charge lands before the clinical decision does.

Nothing about that is hidden and nothing about it is unusual for telehealth. It is worth knowing before you start, because it changes what the price on the page is: it is the price of being assessed and, if the assessment goes one way, supplied. The full set of refund conditions on this roster, including the ones that are not about approval at all, is on what a sermorelin refund covers.

What nobody names

22 of the 88 pages describe their prescribers as board-certified. That is a claim about a category of person, and it is as far as almost every page goes: no page we read tells a reader, before they pay, which individual clinician will review their intake, or in which specialty, or under what medical group.

It is the same shape as the pharmacy question, and the pharmacy answer is starker still — 1 of the 89 companies on this board names the pharmacy that compounds its sermorelin. Who assesses you and who makes the drug are the two identities this market does not print, and both are decided after you have paid.

Questions